Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases—the PURPLE trial

Elez, Elena; Neumann, Ulf; Lang, Sven Arke; Trampe, A. K.; Kasper, Stefan; Salvà, Francesc

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Elez, Elena
dc.contributor.author	Neumann, Ulf
dc.contributor.author	Lang, Sven Arke
dc.contributor.author	Trampe, A. K.
dc.contributor.author	Kasper, Stefan
dc.contributor.author	Salvà, Francesc
dc.date.accessioned	2025-11-07T11:02:43Z
dc.date.available	2025-11-07T11:02:43Z
dc.date.issued	2025-09
dc.identifier.citation	Kasper S, Elez E, Neumann U, Lang S, Trampe AK, Salva F, et al. Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases—the PURPLE trial. ESMO Gastrointest Oncol. 2025 Sep;9:100226.
dc.identifier.issn	2949-8198
dc.identifier.uri	http://hdl.handle.net/11351/14041
dc.description	Metástasis hepáticas colorrectales; Inmunoterapia preoperatoria; Atezolizumab
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartofseries	ESMO Gastrointestinal Oncology;9
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Fetge - Càncer - Immunoteràpia
dc.subject	Còlon - Càncer - Immunoteràpia
dc.subject	Recte - Càncer - Immunoteràpia
dc.subject	Metàstasi
dc.subject	Anticossos monoclonals - Ús terapèutic
dc.subject.mesh	Colorectal Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Neoplasm Metastasis
dc.subject.mesh	Liver Neoplasms
dc.subject.mesh	Immunotherapy
dc.subject.mesh	Antibodies, Monoclonal
dc.subject.mesh	/therapeutic use
dc.title	Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases—the PURPLE trial
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.esmogo.2025.100226
dc.subject.decs	neoplasias colorrectales
dc.subject.decs	/farmacoterapia
dc.subject.decs	metástasis neoplásica
dc.subject.decs	neoplasias hepáticas
dc.subject.decs	inmunoterapia
dc.subject.decs	anticuerpos monoclonales
dc.subject.decs	/uso terapéutico
dc.relation.publishversion	https://doi.org/10.1016/j.esmogo.2025.100226
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Kasper S] Department of Medical Oncology, West German Cancer Center, University Hospital Essen, a member of the imCORE network, Essen, Germany. National Center for Tumor Diseases (NCT), NCT West, Essen, Germany. [Elez E] Department of HPB Surgery and Transplants, Barcelona Hospital Campus, a member of the imCORE network, Barcelona, Spain. [Neumann U] National Center for Tumor Diseases (NCT), NCT West, Essen, Germany. Department of General, Visceral and Transplantation Surgery, West German Cancer Center, University Hospital Essen, a member of the imCORE network, Essen, Germany. [Lang S, Trampe AK] Department of General, Visceral and Transplantation Surgery, West German Cancer Center, University Hospital Essen, a member of the imCORE network, Essen, Germany. [Salva F] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.rights.accessrights	info:eu-repo/semantics/openAccess